• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Brain tumor-polyposis syndrome: two genetic diseases?
 
  • Détails
Titre

Brain tumor-polyposis syndrome: two genetic diseases?

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Journal of Clinical Oncology  
Auteur(s)
Paraf, F.
Auteure/Auteur
Jothy, S.
Auteure/Auteur
Van Meir, E.G.
Auteure/Auteur
Liens vers les unités
Neurochirurgie  
ISSN
0732-183X
Statut éditorial
Publié
Date de publication
1997
Volume
15
Numéro
7
Première page
2744
Dernière page/numéro d’article
2758
Langue
anglais
Notes
Publication types: Journal Article
Résumé
PURPOSE AND DESIGN: This report presents a comprehensive and statistical analysis of the brain tumor-polyposis (BTP) cases referred to as Turcot's syndrome in the literature. RESULTS: BTP patients encompass a heterogeneous group that can be classified into two statistically distinct clinical entities based on phenotype of the polyps (P = .0001), presence of colorectal cancer (P = .0001), type of brain neoplasm, ie, glioma or medulloblastoma (P = .0001), presence of skin lesions (P = .0004) and cafe-au-lait spots (P = .0008), as well as consanguinity (P = .0135). CONCLUSION: The first entity (BTP syndrome type 1) consists of patients who have glioma and colorectal adenomas without polyposis (non-FAP cases), and their siblings with glioma and/or colorectal adenomas. For these patients, we show that the patient's age at malignant glioma occurrence is less than 20 years (50 to 80 years in the general population), which strongly supports the existence of an underlying genetic cause. The neoplasms of these patients show DNA replication errors, which suggests a relationship with hereditary nonpolyposis colorectal cancer (HNPCC), a disease characterized by germline alterations in DNA mismatch repair genes. The second entity (BTP syndrome type 2) consists of patients with a CNS tumor that occurs in a familial adenomatous polyposis kindred (FAP cases). These patients carry germline mutations in the APC gene, which suggests that mutations in this gene might predispose to brain tumors. Risk analysis shows increased incidence of medulloblastoma in FAP patients, but APC mutations are not found in sporadic glioma or medulloblastoma. Therefore, further investigations should establish whether the occurrence of medulloblastoma in an FAP family represents a variant of FAP.
Sujets

Adenomatous Polyposis...

Adenomatous Polyposis...

Brain Neoplasms/compl...

Brain Neoplasms/genet...

Humans

Neoplasms, Multiple P...

Risk Factors

Syndrome

PID Serval
serval:BIB_2211
PMID
9215849
WOS
A1997XH44200035
Permalien
https://iris.unil.ch/handle/iris/64461
Date de création
2007-11-19T11:17:19.598Z
Date de création dans IRIS
2025-05-20T15:50:57Z
  • Copyright © 2024 UNIL
  • Informations légales